Bank of America
COEPW

Bank of America’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Bank of America’s Portfolio COEPW Stock Details COEPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-184
Closed -$2 – 8423
2025
Q1 		$2 Sell
184
-200
-52% -$5 ﹤0.01% 8264
2024
Q4 		$8 Sell
384
-253
-40% -$6 ﹤0.01% 8099
2024
Q3 		$10 Sell
637
-1
-0.2% – ﹤0.01% 8044
2024
Q2 		$10 Buy
638
+38
+6% +$1 ﹤0.01% 8084
2024
Q1 		$15 Buy
600
+100
+20% +$4 ﹤0.01% 7512
2023
Q4 		$16 Buy
500
+300
+150% +$12 ﹤0.01% 7686
2023
Q3 		$4 Buy
+200
New +$8 ﹤0.01% 7676

Other funds holding COEPW

MC
Meteora Capital Boca Raton, Florida $1.36B AUM 20.06% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.79% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Bank of America's COEPW Position: Q2 2025 in Review

Bank of America sold out of Coeptis Therapeutics Warrants (COEPW) in Q2 2025, closing a stake of 184 shares — an estimated $2 sold.

Bank of America first reported a position in COEPW in Q3 2023 and held it in 7 quarters. The position peaked at $16 in Q4 2023. 13 funds tracked by Wall St. Rank hold COEPW as of Q2 2025.

  • Bank of America reported no remaining Coeptis Therapeutics Warrants position as of Q2 2025 after selling out during the quarter.
  • Bank of America sold 184 Coeptis Therapeutics Warrants shares in Q2 2025, an estimated $2.
  • Bank of America first reported a position in Coeptis Therapeutics Warrants in Q3 2023 and held it in 7 quarters.
  • Bank of America's Coeptis Therapeutics Warrants position peaked at $16 in Q4 2023.
  • 13 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q2 2025.

Based on Bank of America's 13F filing for Q2 2025, filed 14 Aug 2025.